Literature DB >> 9572635

The effect of glucocorticoids on fat and lean tissue masses in giant cell arteritis.

E Nordborg1, C Schaufelberger, I Bosaeus.   

Abstract

The aim of the present prospective study over a follow-up period of two years was to assess the influence of various doses of glucocorticosteroids on the total body fat and lean tissue masses and their regional distribution, using DXA technique, in twenty-four patients with giant cell arteritis (GCA). Treatment with glucocorticoids for two years, using high doses of prednisolone the first six months and lower doses thereafter, resulted in a significant increase in total body fat as well as in trunk fat expressed either as absolute values or as a proportion of body weight. The abnormal accumulation of fat mass remained also after switching to a low dose glucocorticoid schedule. There was no redistribution of fat from peripheral areas to central parts of the body and there was no depletion of lean tissue at peripheral sites.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572635     DOI: 10.1080/030097498440967

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  3 in total

1.  Development of an evidence-based regimen of prednisolone to treat giant cell arteritis - the Norwich regimen.

Authors:  Chetan Mukhtyar; Heidi Cate; Conor Graham; Peter Merry; Karen Mills; Aseema Misra; Colin Jones
Journal:  Rheumatol Adv Pract       Date:  2019-02-01

2.  Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis.

Authors:  Amir Emamifar; Torkell Ellingsen; Anne Pernille Hermann; Søren Hess; Oke Gerke; Ziba Ahangarani Farahani; Per Syrak Hansen; Inger Marie Jensen Hansen; Peter Thye-Rønn
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

3.  Effects of low-dose prednisolone on hepatic and peripheral insulin sensitivity, insulin secretion, and abdominal adiposity in patients with inflammatory rheumatologic disease.

Authors:  Carolyn J Petersons; Brenda L Mangelsdorf; Arthur B Jenkins; Anne Poljak; Malcolm D Smith; Jerry R Greenfield; Campbell H Thompson; Morton G Burt
Journal:  Diabetes Care       Date:  2013-05-13       Impact factor: 19.112

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.